Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
出版年份 2019 全文链接
标题
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-30
DOI
10.1038/s41598-019-43228-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water
- (2018) Xue-Jing Liu et al. LABORATORY INVESTIGATION
- Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis
- (2018) Wei Ma et al. Frontiers in Microbiology
- Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
- (2018) Charlotte J. Green et al. DIABETES OBESITY & METABOLISM
- Regulatory Efficacy of the Polyunsaturated Fatty Acids from Microalgae Spirulina platensis on Lipid Metabolism and Gut Microbiota in High-Fat Diet Rats
- (2018) Tian-Tian Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
- (2017) Elina Manzhalii et al. Journal of Digestive Diseases
- Bacterial communities in the small intestine respond differently to those in the caecum and colon in mice fed low- and high-fat diets
- (2017) Janet C. Onishi et al. MICROBIOLOGY-SGM
- Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function
- (2017) Anna Janina Engstler et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
- (2017) Annette Brandt et al. Nutrients
- Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
- (2017) Li Xue et al. Scientific Reports
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- The gut microbiota as a modulator of innate immunity during melioidosis
- (2017) Jacqueline M. Lankelma et al. PLoS Neglected Tropical Diseases
- Effect of Bacillus subtilis and Bacillus licheniformis supplementation in diets with low- and high-protein content on ileal crude protein and amino acid digestibility and intestinal microbiota composition of growing pigs
- (2017) Chanwit Kaewtapee et al. Journal of Animal Science and Biotechnology
- Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
- (2017) Anika Nier et al. PLoS One
- Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
- (2017) Da Zhou et al. Scientific Reports
- Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling
- (2016) Zi-yu Zhou et al. ACTA PHARMACOLOGICA SINICA
- Metformin Is Associated With Higher Relative Abundance of Mucin-DegradingAkkermansia muciniphilaand Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
- (2016) Jacobo de la Cuesta-Zuluaga et al. DIABETES CARE
- Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD)
- (2016) Cathrin Sellmann et al. EUROPEAN JOURNAL OF NUTRITION
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Dietary fat drives whole-body insulin resistance and promotes intestinal inflammation independent of body weight gain
- (2016) Benjamin A.H. Jensen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)
- (2015) Cheng Jun Jin et al. BRITISH JOURNAL OF NUTRITION
- Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
- (2015) Irina A. Kirpich et al. CLINICAL BIOCHEMISTRY
- Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages
- (2015) Beth Kelly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis
- (2015) Cathrin Sellmann et al. JOURNAL OF NUTRITION
- Effect of Metformin on Metabolic Improvement and Gut Microbiota
- (2014) Heetae Lee et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
- (2014) Maryann Maximos et al. HEPATOLOGY
- Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform
- (2013) James J. Kozich et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
- (2013) Roosmarijn E. Vandenbroucke et al. EMBO Molecular Medicine
- Comparing the anterior nare bacterial community of two discrete human populations using Illumina amplicon sequencing
- (2013) Amélia Camarinha-Silva et al. ENVIRONMENTAL MICROBIOLOGY
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity
- (2013) Alini Schultz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
- (2012) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
- (2012) Valentina Volynets et al. DIGESTIVE DISEASES AND SCIENCES
- Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function
- (2012) Astrid Spruss et al. LABORATORY INVESTIGATION
- Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes
- (2012) Noga Budick-Harmelin et al. Lipids in Health and Disease
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
- (2012) Yuki Kita et al. PLoS One
- Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis
- (2011) Sabine Wagnerberger et al. BRITISH JOURNAL OF NUTRITION
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice
- (2010) Astrid Spruss et al. ANTIOXIDANTS & REDOX SIGNALING
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice
- (2010) Valentina Volynets et al. JOURNAL OF LIPID RESEARCH
- Kupffer cell activation is a causal factor for hepatic insulin resistance
- (2009) Nicolas Lanthier et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
- (2009) Zheng-Jie Xu et al. DIGESTIVE DISEASES AND SCIENCES
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure
- (2009) Feng Chen et al. HEPATOLOGY
- The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
- (2009) P. J. Turnbaugh et al. Science Translational Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search